A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Clinical trial NCT02019264 · COMPLETED
Trial details
- NCT number
- NCT02019264
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-24
- Primary completion
- 2018-05-14
- Enrollment
- 14673
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.